Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes
Clinical trial NCT07198932 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07198932
- Sponsor
- Yanbing Li
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-10-01
- Primary completion
- 2027-07-31
- Enrollment
- 594
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.